Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2019-03-06

Clinical Trial Update: Study of Progesterone in Treatment of Vasomotor Symptoms [Phase 3]

View source ↗

Summary

Phase 3 trial of progesterone for vasomotor symptoms in menopause was terminated.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • PROGESTERONE (Progesterone)

Snippet

Sponsor: BHR Pharma, LLC | Conditions: Menopause Related Conditions | Phase 3 | Status: TERMINATED